CDXC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.57%

Insider Buying (Last 12 Months): $31,990.00

Insider Selling (Last 12 Months): $0.00

ChromaDex Insider Trading History Chart

ChromaDex Share Price & Price History

^$1.41

▲ +0.02 (1.44%)

As of 12/1/2023 01:00 AM ET

Days: 30 | 90 | 365

New CBOE “special perk” helps traders target income every weekend

From DTI Trader | Ad

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

Check out this training for the full story!

ChromaDex Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/12/2023	Frank L Jaksch Jr	Director	Buy	7,000	$1.69	$11,830.00	231,339
5/31/2023	Robert N. Fried	CEO	Buy	7,000	$1.42	$9,940.00	95,001
5/25/2023	Steven D Rubin	Director	Buy	7,000	$1.46	$10,220.00	7,000
9/30/2022	Hoi Shuen Solina Holly Chau	Major Shareholder	Buy	960,000	$1.25	$1,200,000.00	7,885,641
9/30/2022	Robert N. Fried	Insider	Buy	80,000	$1.25	$100,000.00	972,314
6/16/2022	Hoi Shuen Solina Holly Chau	Major Shareholder	Buy	60,037	$1.66	$99,661.42	6,925,641
3/16/2022	Robert N. Fried	CEO	Buy	25,000	$2.16	$54,000.00
5/13/2021	Robert N. Fried	CEO	Buy	10,000	$6.65	$66,500.00	882,561
3/16/2021	Stephen A. Block	Director	Sell	20,000	$13.17	$263,400.00	49,167
12/10/2020	Frank L Jaksch Jr	Chairman	Sell	37,829	$5.19	$196,332.51	262,168

All the trading advice you’ve ever received boils down to this

From DTI Trader | Ad

All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.

Drop everything and learn about the Income Calendar now.

SEC Filings (Institutional Ownership Changes) for ChromaDex (NASDAQ:CDXC)

14.99% of ChromaDex stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ChromaDex Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	83,031	$0.12M	0.0%	+121.9%	0.111%
11/8/2023	Gabelli Funds LLC	180,000	$0.26M	0.0%	+9.1%	0.240%
11/8/2023	Gamco Investors INC. ET AL	259,850	$0.38M	0.0%	+26.5%	0.346%
11/1/2023	Tieton Capital Management LLC	2,451,983	$3.58M	2.3%	-4.6%	3.268%
10/24/2023	Cambridge Investment Research Advisors Inc.	122,918	$0.18M	0.0%	-17.1%	0.164%
10/10/2023	Cox Capital Mgt LLC	92,830	$0.14M	0.1%	N/A	0.124%
8/15/2023	Gamco Investors INC. ET AL	205,350	$0.32M	0.0%	+16.3%	0.274%
8/15/2023	Tieton Capital Management LLC	2,570,148	$4.04M	2.6%	+0.8%	3.425%
8/11/2023	Renaissance Technologies LLC	460,539	$0.72M	0.0%	+7.8%	0.614%
8/11/2023	BlackRock Inc.	913,818	$1.44M	0.0%	+1.4%	1.219%
8/11/2023	Geode Capital Management LLC	524,399	$0.82M	0.0%	-5.9%	0.699%
8/10/2023	Gamco Investors INC. ET AL	205,350	$0.32M	0.0%	+16.3%	0.274%
8/10/2023	Gabelli Funds LLC	165,000	$0.26M	0.0%	+5.2%	0.220%
8/4/2023	Envestnet Asset Management Inc.	16,005	$25K	0.0%	N/A	0.021%
7/31/2023	LPL Financial LLC	28,915	$45K	0.0%	+52.9%	0.039%
7/13/2023	Cambridge Investment Research Advisors Inc.	148,343	$0.23M	0.0%	-23.8%	0.198%
5/16/2023	Susquehanna International Group LLP	108,947	$0.17M	0.0%	N/A	0.145%
5/16/2023	State Street Corp	190,239	$0.29M	0.0%	+7.6%	0.254%
5/16/2023	Squarepoint Ops LLC	17,983	$28K	0.0%	N/A	0.024%
5/15/2023	Two Sigma Securities LLC	45,688	$70K	0.0%	N/A	0.061%
5/15/2023	Two Sigma Advisers LP	30,100	$46K	0.0%	-38.8%	0.040%
5/12/2023	Renaissance Technologies LLC	427,200	$0.65M	0.0%	-25.2%	0.571%
5/12/2023	Gabelli Funds LLC	156,800	$0.24M	0.0%	+201.5%	0.209%
5/12/2023	Gamco Investors INC. ET AL	176,550	$0.27M	0.0%	N/A	0.236%
5/12/2023	BlackRock Inc.	901,196	$1.38M	0.0%	-8.4%	1.204%
5/12/2023	Bank of America Corp DE	16,469	$25K	0.0%	+130.4%	0.022%
5/12/2023	Crestwood Advisors Group LLC	22,023	$34K	0.0%	-41.9%	0.029%
5/11/2023	Cambridge Investment Research Advisors Inc.	194,558	$0.30M	0.0%	+53.7%	0.260%
5/10/2023	Resources Investment Advisors LLC.	55,042	$84K	0.0%	+101.7%	0.074%
5/10/2023	Tieton Capital Management LLC	2,548,710	$3.90M	2.8%	-7.2%	3.405%
5/9/2023	GMT Capital Corp	296,905	$0.45M	0.0%	N/A	0.397%
5/1/2023	Virtu Financial LLC	17,377	$27K	0.0%	N/A	0.023%
2/15/2023	Susquehanna Fundamental Investments LLC	43,662	$73K	0.0%	-22.3%	0.059%
2/15/2023	Millennium Management LLC	662,867	$1.11M	0.0%	+230.3%	0.890%
2/15/2023	Morgan Stanley	14,696	$25K	0.0%	-42.2%	0.020%
2/14/2023	Price T Rowe Associates Inc. MD	39,300	$66K	0.0%	+74.7%	0.053%
2/14/2023	Two Sigma Investments LP	76,850	$0.13M	0.0%	+63.8%	0.103%
2/13/2023	Gabelli Funds LLC	52,000	$87K	0.0%	+85.7%	0.070%
2/13/2023	Barclays PLC	100,000	$0.17M	0.0%	-66.0%	0.134%
2/13/2023	Renaissance Technologies LLC	570,900	$0.96M	0.0%	-7.7%	0.767%
2/13/2023	Geode Capital Management LLC	558,849	$0.94M	0.0%	+1.0%	0.750%
2/13/2023	GSA Capital Partners LLP	79,868	$0.13M	0.0%	N/A	0.107%
2/10/2023	Tieton Capital Management LLC	2,745,024	$4.61M	3.0%	+20.6%	3.686%
2/8/2023	UBS Group AG	17,409	$29K	0.0%	-27.2%	0.023%
2/8/2023	Cambridge Investment Research Advisors Inc.	126,558	$0.21M	0.0%	+5.9%	0.170%
2/1/2023	Cowen Prime Advisors LLC	75,357	$0.13M	0.1%	+1,694.2%	0.101%
1/30/2023	International Assets Investment Management LLC	20,000	$34K	0.0%	N/A	0.027%
11/15/2022	State Street Corp	176,839	$0.22M	0.0%	-25.4%	0.237%
11/15/2022	Two Sigma Advisers LP	42,000	$52K	0.0%	-19.7%	0.056%
11/15/2022	Two Sigma Investments LP	46,925	$58K	0.0%	-72.7%	0.063%
11/15/2022	Vanguard Group Inc.	2,231,297	$2.74M	0.0%	+2.2%	2.996%
11/15/2022	Marshall Wace LLP	82,092	$0.10M	0.0%	+66.0%	0.110%
11/15/2022	BlackRock Inc.	983,046	$1.21M	0.0%	-0.6%	1.320%
11/14/2022	Gabelli Funds LLC	28,000	$34K	0.0%	N/A	0.038%
11/14/2022	Royal Bank of Canada	75,645	$93K	0.0%	N/A	0.102%
11/14/2022	Renaissance Technologies LLC	618,210	$0.76M	0.0%	-16.4%	0.830%
11/14/2022	Ergoteles LLC	127,211	$0.16M	0.0%	-44.8%	0.171%
11/14/2022	Tieton Capital Management LLC	2,275,595	$2.80M	2.0%	-0.4%	3.056%
11/14/2022	Oppenheimer & Co. Inc.	30,200	$37K	0.0%	-22.8%	0.041%
11/10/2022	Gabelli Funds LLC	28,000	$34K	0.0%	N/A	0.038%
10/28/2022	Yong Rong HK Asset Management Ltd	1,933,041	$2.38M	7.6%	-28.6%	2.829%
10/17/2022	Cambridge Investment Research Advisors Inc.	119,558	$0.15M	0.0%	+30.1%	0.175%
8/18/2022	Goldman Sachs Group Inc.	323,078	$0.54M	0.0%	-9.1%	0.473%
8/16/2022	Price T Rowe Associates Inc. MD	22,500	$38K	0.0%	-57.8%	0.033%
8/15/2022	AQR Capital Management LLC	232,803	$0.39M	0.0%	-43.7%	0.341%
8/15/2022	State Street Corp	237,099	$0.40M	0.0%	-74.6%	0.347%
8/15/2022	Cubist Systematic Strategies LLC	63,286	$0.11M	0.0%	+142.3%	0.093%
8/15/2022	Millennium Management LLC	763,593	$1.28M	0.0%	N/A	1.117%
8/13/2022	Virtu Financial LLC	45,455	$76K	0.0%	N/A	0.067%
8/13/2022	Renaissance Technologies LLC	739,900	$1.24M	0.0%	+76.0%	1.083%
8/12/2022	Northern Trust Corp	90,337	$0.15M	0.0%	-78.9%	0.132%
8/10/2022	Tieton Capital Management LLC	2,285,015	$3.82M	2.6%	+59.9%	3.344%
8/8/2022	Oppenheimer & Co. Inc.	39,110	$65K	0.0%	+127.3%	0.057%
7/26/2022	Yong Rong HK Asset Management Ltd	2,709,036	$4.53M	3.5%	-33.5%	3.965%
6/7/2022	Bank of America Corp DE	792,551	$1.95M	0.0%	-44.3%	1.160%
5/16/2022	Goldman Sachs Group Inc.	355,358	$0.87M	0.0%	-17.6%	0.520%
5/16/2022	PDT Partners LLC	27,243	$67K	0.0%	-60.0%	0.040%
5/16/2022	State Street Corp	932,526	$2.29M	0.0%	+4.1%	1.365%
5/16/2022	UBS Group AG	21,675	$53K	0.0%	-60.6%	0.032%
5/13/2022	Renaissance Technologies LLC	420,501	$1.03M	0.0%	+1,004.0%	0.615%
5/13/2022	Northern Trust Corp	428,817	$1.05M	0.0%	-4.6%	0.628%
5/13/2022	XTX Topco Ltd	30,998	$76K	0.0%	N/A	0.045%
5/13/2022	Vanguard Group Inc.	2,781,437	$6.84M	0.0%	+9.5%	4.071%
5/12/2022	BlackRock Inc.	3,153,709	$7.76M	0.0%	-1.3%	4.615%
5/12/2022	Oppenheimer & Co. Inc.	17,210	$42K	0.0%	-31.5%	0.025%
5/12/2022	Cambridge Investment Research Advisors Inc.	97,408	$0.24M	0.0%	+30.0%	0.143%
5/11/2022	JPMorgan Chase & Co.	51,840	$0.13M	0.0%	+184.6%	0.076%
5/11/2022	GSA Capital Partners LLP	54,289	$0.13M	0.0%	N/A	0.079%
5/10/2022	Tieton Capital Management LLC	1,428,742	$3.52M	1.9%	+242.8%	2.091%
5/4/2022	Yong Rong HK Asset Management Ltd	4,074,939	$10.03M	14.2%	-1.4%	5.964%
4/28/2022	Merriman Wealth Management LLC	11,800	$29K	0.0%	N/A	0.017%
4/12/2022	Crestwood Advisors Group LLC	34,359	$85K	0.0%	N/A	0.050%
2/23/2022	Barclays PLC	776,301	$2.90M	0.0%	-18.9%	1.137%
2/14/2022	PDT Partners LLC	68,156	$0.26M	0.0%	+13.6%	0.100%
2/14/2022	Barclays PLC	776,301	$2.90M	0.0%	-18.9%	1.137%
2/10/2022	Tieton Capital Management LLC	416,726	$1.56M	0.9%	+38.5%	0.610%
2/10/2022	Campbell & CO Investment Adviser LLC	10,100	$38K	0.0%	N/A	0.015%
2/9/2022	Keebeck Alpha LP	14,865	$56K	0.0%	N/A	0.022%
2/8/2022	Bank of America Corp DE	1,422,359	$5.32M	0.0%	-0.6%	2.083%
2/8/2022	ProShare Advisors LLC	10,240	$38K	0.0%	N/A	0.015%

Data available starting January 2016

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.

Today's Range

Now: $1.41

$1.36

$1.45

50 Day Range

MA: $1.39

$1.28

$1.60

52 Week Range

Now: $1.41

$1.25

$2.24

Volume

110,984 shs

Average Volume

115,761 shs

Market Capitalization

$105.92 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.77

Who are the company insiders with the largest holdings of ChromaDex?: ChromaDex's top insider shareholders include:
Hoi Shuen Solina Holly Chau (Major Shareholder)
Robert N Fried (Insider)
Frank L Jaksch Jr (Director)
Robert N Fried (CEO)
Steven D Rubin (Director)
Learn More about top insider investors at ChromaDex.
Who are the major institutional investors of ChromaDex?: ChromaDex's top institutional shareholders include:
Tieton Capital Management LLC — 3.27%
Gamco Investors INC. ET AL — 0.35%
Gabelli Funds LLC — 0.24%
Cambridge Investment Research Advisors Inc. — 0.16%
Cox Capital Mgt LLC — 0.12%
Connor Clark & Lunn Investment Management Ltd. — 0.11%
Learn More about top institutional investors of ChromaDex stock.
Which institutional investors are selling ChromaDex stock?: During the previous quarter, CDXC stock was sold by these institutional investors:
Tieton Capital Management LLC
Cambridge Investment Research Advisors Inc.
Group One Trading L.P.
Which institutional investors are buying ChromaDex stock?: Within the last quarter, CDXC stock was bought by institutional investors including:
Cox Capital Mgt LLC
Gamco Investors INC. ET AL
Connor Clark & Lunn Investment Management Ltd.
Gabelli Funds LLC
In the previous year, these company insiders have bought ChromaDex stock:
Hoi Shuen Solina Holly Chau (Major Shareholder)
Robert N Fried (Insider)
Frank L Jaksch Jr (Director)
Robert N Fried (CEO)
Steven D Rubin (Director)
Learn More investors buying ChromaDex stock.